Media
Media
Our latest press releases
Hansa Biopharma interim report January-March 2024
Regulatory press release
18/04/2024
Hansa Biopharma Announces Successful Execution of a Directed Share Issue of SEK 372 million (~USD 34.6 million)
Regulatory press release
12/04/2024
Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance
Regulatory press release
02/04/2024
Hansa Biopharma publishes 2023 Annual and Sustainability Reports
Regulatory press release
21/03/2024
Media
News and insights
Neutralizing antibodies: Addressing barriers to gene therapy treatment
31/01/2024
At the intersection of patient-centered care and disruptive science
24/10/2023
Building a better knowledge of anti-GBM disease
10/05/2023
Acknowledging Disparities Between Sexes in Kidney Transplantation this World Kidney Day
09/03/2023